News

Today, Wednesday, November 5th, researcher Marta Cuadros, head of the Ae22-Cancer Genetics, Biomarkers and Experimental Therapies group, participated in a Science Coffee session with 30 first-year high school students from IES La Madraza. During the meeting, entitled “Why Become a Researcher?”, Cuadros shared her professional career path with the students […]

The ibs.GRANADA Biomedical Research Institute inaugurated its Science Week activities today, Tuesday, November 4th, with two meetings dedicated to health and prevention from different perspectives. On the one hand, researchers Víctor Segura Jiménez, Iván Aguilera García, María López Corchón, and Gavriella Tsiarleston, from the TECE20–Rehabilita-T group: Advances […]

The study demonstrates that β-resorcylic acid prevents the progression of liver disease to more severe stages by reducing fat accumulation and inflammation. A team of researchers from the University of Granada and ibs.GRANADA has discovered that β-resorcylic acid (β-RA), a naturally occurring compound, can slow the progression of […]

Held at the Faculty of Medicine of the University of Granada, the meeting brought together around one hundred healthcare professionals, researchers, and patient associations to share advances in personalized medicine and foster synergies. The Granada Institute for Biomedical Research (ibs.GRANADA) held its 6th Symposium on Precision Medicine under the theme […]

The delegate of the Andalusian Regional Government in Granada, Antonio Granados, today gave a "very positive" assessment of the Investigo Program, an initiative of the Ministry of Employment, Business and Self-Employment (CEETA) that has enabled the hiring of nearly 150 young researchers in the province thanks to an investment of over 10 million euros. During his visit […]

The Víctor Grífols i Lucas Foundation has awarded one of its 2025 Bioethics Research Grants to the project “Embryos without a Destination: Ethical Conflicts and Decisions Regarding the Reproductive Donation of Abandoned Cryopreserved Embryos,” led by Nerea Molina Morales, a researcher affiliated with the Youngner Chair of Empirical Bioethics.

The study, published in the Journal of Nanobiotechnology, focuses on miR-122, an indicator of liver health, and identifies very subtle variants of the microRNA that can point to different pathologies. The NanoChemBio research group from the Granada Institute for Biomedical Research (ibs.GRANADA) and the Department of Pharmaceutical and Organic Chemistry of the University of Granada conducted the research.